View Clinical Trial (Medical Research Study)


Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects - NCT00888069-54601(Clinical Trial 349789)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup

City:  La Crosse
State:  
WI
Zip Code: 54601
Conditions: Chronic Kidney Disease - Secondary Hyperparathyroidism - Chronic Renal Insufficiency - Chronic Renal Failure
Purpose: This study will investigate how the levels of a single dose of CTAP101 changes in the body over time (pharmacokinetics, PK) and how CTAP101 affects other mineral and hormonal balances (pharmacodynamics, PD) in patients with Stage 3 or 4 chronic kidney disease (CKD) with vitamin D insufficiency and secondary hyperparathyroidism (SHPT).
Study summary:
Criteria: Inclusion Criteria: - Body mass index between great than or equal to 18 and less than or equal to 40 kg/m2 - Plasma iPTH value for Stage 3 CKD greater than or equal to 70 pg/mL and lower than or equal to 1000 pg/mL - Plasma iPTH value for Stage 4 CKD greater than or equal to 110 pg/mL and lower than or equal to 1000 pg/mL - Adjusted serum total calcium value greater than 8.4 mg/dL and lower than 10.0 mg/dL - Serum phosphorus value greater than or equal to 2.5 mg/dL and lower than or equal to 5.5 mg/dL - Serum 25-hydroxyvitamin D level greater than 15 ng/mL and lower than 30 ng/mL - Hemoglobin level greater than or equal to 10 g/dL Exclusion Criteria: - Has nephrotic range proteinuria - Has liver disease or significant hepatic dysfunction - Is taking Cytochrome P450 3A4 inhibitors or inducers - Has adult history of kidney stones and dysphagia - Has known history of alcohol/controlled substance abuse or are positive for drug of abuse screen - Currently on dialysis - Current serious illness such as cancer, HIV, cardiovascular event or hepatitis
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.

Data Source: ClinicalTrials.gov
Date Processed: February 17, 2010
Modifications to
this listing:
Only selected fields are shown, please use the link above to view all information about this clinical trial.